SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-152493
Filing Date
2013-04-12
Accepted
2013-04-12 12:27:41
Documents
4
Period of Report
2013-05-23
Effectiveness Date
2013-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d478892ddef14a.htm DEF 14A 391978
2 GRAPHIC g478892g25o33.jpg GRAPHIC 8319
3 GRAPHIC g478892g29l65.jpg GRAPHIC 8930
4 GRAPHIC g478892g64d68.jpg GRAPHIC 12703
  Complete submission text file 0001193125-13-152493.txt   434829
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31791 | Film No.: 13758134
SIC: 2834 Pharmaceutical Preparations